August 1, 2018 A new method published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging constructs networks based on multiple structural features to identify Alzheimer’s disease and mild cognitive impairment Researchers have developed a new method for constructing personal brain networks using multiple structural features to improve the accuracy of diagnosing Alzheimer’s disease (AD) and mild […]Continue Reading ...
(HealthDay)—Atopic dermatitis (AD) dramatically impacts the quality of life of patients, according to a study published online July 16 in the Annals of Allergy, Asthma & Immunology. Jonathan I. Silverberg, M.D., Ph.D., from Northwestern University in Chicago, and colleagues assessed the patient-burden of AD among 602 U.S. patients. The researchers found that adults with AD […]Continue Reading ...
July 24, 2018 Roche announced today,that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Elecsys® ß-Amyloid (1-42) CSF and Elecsys® Phospho-Tau (181P) CSF. These in vitro diagnostic immunoassays are for the measurement of the ß-Amyloid (1-42) and Phospho-Tau concentrations in cerebrospinal fluid (CSF) in adult patients with cognitive impairment who […]Continue Reading ...
July 20, 2018 Sage Bionetworks announces the launch of the Agora platform (agora.ampadportal.org) an interactive, web-based tool that allows researchers to explore curated genomic analyses of Alzheimer’s Disease (AD), including a list of early candidate target nominations for AD. The analyses accessible through Agora represent the culmination of over five years of research from the […]Continue Reading ...
June is Alzheimer’s and Brain Awareness Month. Alzheimer’s disease (AD) is the most common form of dementia. It takes a devastating toll on patients and family members, who are usually the caregivers. Current drugs only treat symptoms of AD, not its causes. FIU researchers are studying a new approach to treating Alzheimer’s using nanotechnology aimed […]Continue Reading ...
June 25, 2018 Researchers from Queen’s University Belfast have shown for the first time that the eye could be a surrogate for brain degeneration like Alzheimer’s disease (AD). This research results have recently been published in the Journal of Ophthalmic Research andis the first clinical study showing a potential for peripheral retinal imaging to be […]Continue Reading ...
May 29, 2018 After a decade of work, a team led by Hôpital Maisonneuve-Rosemont researcher and Université de Montréal associate professor Dr. Gilbert Bernier has shed promising light on the origin of the most common and prevalent form of Alzheimer’s disease, hoping to someday help mitigate or even reverse the progress of the disease. The […]Continue Reading ...
William Kremen, PhD, professor of psychiatry at UC San Diego School of Medicine. Credit: UC San Diego Health For the first time, an international team of scientists, led by researchers at University of California San Diego School of Medicine, have determined that an Alzheimer’s disease (AD) polygenic risk score can be used to correctly identify […]Continue Reading ...
July 26, 2018 BIOCRATES’ Technology Enables Research of Host Microbiome Interactions to Investigate Neurodegenerative Diseases BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer’s Disease Metabolomics Consortium’s (ADMC) new breakthrough in Alzheimer’s research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer’s disease (AD). During the Alzheimer’s […]Continue Reading ...
July 23, 2018 The MODEL-AD Center, an ambitious project to develop and distribute precise mouse models of late-onset Alzheimer’s disease (AD), has released eight new models carrying genetic mutations found in patients. In past decades, most AD researchers had to rely on mouse models that carried a genetic mutation associated with the relatively rare, early-onset, […]Continue Reading ...
July 16, 2018 If you had your genome sequenced and the report says you have the APOEε4 mutation, it does not mean you are definitely going to get Alzheimer’s disease. The reason why is complicated. The specific genetic variant known as APOEε4 (the ε4 mutation of Apolipoprotein E) is the greatest genetic risk factor for […]Continue Reading ...
Credit: Queen’s University Belfast Researchers from Queen’s University Belfast have shown for the first time that the eye could be a surrogate for brain degeneration like Alzheimer’s disease (AD). This research results have recently been published in the Journal of Ophthalmic Research and is the first clinical study showing a potential for peripheral retinal imaging […]Continue Reading ...
May 30, 2018 After a decade of work, a team led by Hôpital Maisonneuve-Rosemont researcher and Université de Montréal associate professor Dr. Gilbert Bernier has shed promising light on the origin of the most common and prevalent form of Alzheimer’s disease, hoping to someday help mitigate or even reverse the progress of the disease. The […]Continue Reading ...
Coronal section of human brain indicating the lateral temporal lobe (red circle) used in this study. Credit: Coronal section of human brain indicating The lab of Shelley Berger, PhD, Perelman School of Medicine, University of Pennsylvania Although certain genetic variants increase the risk of Alzheimer’s disease (AD), age is the strongest known risk factor. But […]Continue Reading ...
Action Points Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. SAN DIEGO — Patients with moderate or severe atopic dermatitis (AD) had as much as 74% improvement in disease status with the oral […]Continue Reading ...
- Team explores diabetes drug’s ability to treat RSV infection
- New imaging technique can spot tuberculosis infection in an hour | News Center
- PolyU researchers design new self-fitting scaffold to induce bone regeneration
- CartiHeal and LSU Health successfully enroll first two patients in Agili-C IDE pivotal study
- Less-invasive options are slowing disease progression in glaucoma patients
- Researchers discover new promising target point for cancer and diabetes therapies
- Podcast: KHN’s ‘What the Health?’ See you in court!
- New mobile phone application enables early detection of cerebral ictus
- UK’s leading sight loss charity invites applications from brightest minds in ophthalmic research
- Researchers produce artificial placenta model that closely resembles natural organ
- FDA Alert: Temporary Total Artificial Heart Companion 2 Driver System by SynCardia Systems: Letter to Health Care Providers
- Researchers discover why sepsis from a staph infection causes organ failure
- Revealed: The molecular mechanism underlying hypertrophic cardiomyopathy | News Center
- Research explores relationship between personal history of infectious fever and cancer risk
- Study finds rise in cases of progressive massive fibrosis among U.S. coal miners
- NEDBELS project examines impact of neurodiversity concept on legal systems
- Seeking solutions to treat scleroderma
- Statins may improve conditions of people with rare lung disease
- Study finds why some people with brain markers of Alzheimer’s never develop dementia
- Life Biosciences contributes $100,000 to fund its biomedical innovation course on aging